Your browser doesn't support javascript.
loading
Phenotype description and response to thrombopoietin receptor agonist in DIAPH1-related disorder.
Westbury, Sarah K; Downes, Kate; Burney, Claire; Lozano, Maria L; Obaji, Samya G; Toh, Cheng Hock; Sevivas, Teresa; Morgan, Neil V; Erber, Wendy N; Kempster, Carly; Moore, Samantha F; Thys, Chantal; Papadia, Sofia; Ouwehand, Willem H; Laffan, Michael A; Gomez, Keith; Freson, Kathleen; Rivera, Jose; Mumford, Andrew D.
Afiliação
  • Westbury SK; School of Cellular and Molecular Medicine and.
  • Downes K; School of Clinical Sciences, University of Bristol, Bristol, United Kingdom.
  • Burney C; NIHR BioResource-Rare Diseases, Cambridge University Hospitals, Cambridge, United Kingdom.
  • Lozano ML; NIHR BioResource-Rare Diseases, Cambridge University Hospitals, Cambridge, United Kingdom.
  • Obaji SG; Department of Haematology, University of Cambridge, Cambridge Biomedical Campus, Cambridge, United Kingdom.
  • Toh CH; NHS Blood and Transplant, Cambridge Biomedical Campus, Cambridge, United Kingdom.
  • Sevivas T; University Hospitals Bristol NHS Foundation Trust, Bristol, United Kingdom.
  • Morgan NV; Servicio de Hematología y Oncología Médica, Hospital Universitario Morales Meseguer, Centro Regional de Hemodonación, Universidad de Murcia, IMIB-Arrixaca, CIBERER-U765, Murcia, Spain.
  • Erber WN; Department of Haematology, School of Medicine, Cardiff University, Cardiff, United Kingdom.
  • Kempster C; Roald Dahl Haemostasis and Thrombosis Centre, Royal Liverpool University Hospital, Liverpool, United Kingdom.
  • Moore SF; Institute of Infection and Global Health, University of Liverpool, Liverpool, United Kingdom.
  • Thys C; Serviço de Sangue, Medicina Transfusional e Imunohemoterapia do Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal.
  • Papadia S; Institute of Cardiovascular Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom.
  • Ouwehand WH; NIHR BioResource-Rare Diseases, Cambridge University Hospitals, Cambridge, United Kingdom.
  • Laffan MA; School of Biomedical Science, University of Western Australia, Crawley, WA, Australia.
  • Gomez K; PathWest Laboratory Medicine WA, Nedlands, WA, Australia.
  • Freson K; Department of Haematology, University of Cambridge, Cambridge Biomedical Campus, Cambridge, United Kingdom.
  • Rivera J; NHS Blood and Transplant, Cambridge Biomedical Campus, Cambridge, United Kingdom.
  • Mumford AD; School of Physiology, Pharmacology and Neuroscience, University of Bristol, Bristol, United Kingdom.
Blood Adv ; 2(18): 2341-2346, 2018 09 25.
Article em En | MEDLINE | ID: mdl-30232087
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fenótipo / Proteínas Adaptadoras de Transdução de Sinal / Receptores de Trombopoetina / Estudos de Associação Genética Tipo de estudo: Prognostic_studies Limite: Adolescent / Adult / Aged / Child / Child, preschool / Female / Humans / Male / Middle aged Idioma: En Revista: Blood Adv Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fenótipo / Proteínas Adaptadoras de Transdução de Sinal / Receptores de Trombopoetina / Estudos de Associação Genética Tipo de estudo: Prognostic_studies Limite: Adolescent / Adult / Aged / Child / Child, preschool / Female / Humans / Male / Middle aged Idioma: En Revista: Blood Adv Ano de publicação: 2018 Tipo de documento: Article